Asker Healthcare Group intends to list on Nasdaq Stockholm

“Asker has grown to become a leading European provider of medical products and solutions, and a key partner to the European healthcare system. Addressing a market worth more than SEK 1,300bn, significantly outgrowing the underlying market, with broad opportunities for continued consolidation, we believe a listing will increase Asker’s visibility and financial flexibility and by that enable the company to further grow and strengthen its already strong position. We welcome all new owners to this continued growth journey and look forward to supporting Asker as the main long-term shareholder in a public environment.” says Martin Lagerblad, Managing Director, Nalka Invest

Read more here: